We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa (CELEB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03578029
Recruitment Status : Terminated (Business Decision)
First Posted : July 5, 2018
Last Update Posted : August 22, 2022
Information provided by (Responsible Party):
Lenus Therapeutics, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : September 1, 2021
Actual Study Completion Date : November 23, 2021
Certification/Extension First Submitted : August 18, 2022